https://doi.org/
Slides
NOT PEER REVIEWED
Download
metrics
VIEWS
132
 
downloads
25
CITE
How to cite these slides:
Copeland R. Protein methyl transferases: A novel target class for molecularly targeted therapy against genetically defined cancers. F1000Posters 2011, 2:1253 (slides)

Protein methyl transferases: A novel target class for molecularly targeted therapy against genetically defined cancers

Published 23 Aug 2011
Author Affiliations
  • Metrics
  • 132 Views
  • 25 Downloads
Browse by related subjects
Published 23 Aug 2011

Protein methyl transferases: A novel target class for molecularly targeted therapy against genetically defined cancers

[version 1; not peer reviewed]

Author Affiliations
1 Epizyme, Inc., USA
Presented at
GeneExpression Systems - Epigenomics, Sequencing & SNiPomics meeting 2011
Abstract
Competing Interests

Robert Copeland is a paid employee and a stockholder of Epizyme, Inc.

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.